Clinical Trial Update: SKB500 Combinations in Patients With Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial evaluating SKB500 in combination regimens for patients with Small Cell Lung Cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• SKB500

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Small Cell Lung Cancer | Phase 2 | Status: RECRUITING